Rainbow Seed Fund News

Collaboration to generate tumor targeting drug conjugates and immuno-oncology therapeutics Crescendo Biologics Limited (Crescendo), the drug discovery and developer of Humabody®-based therapeutics, and Takeda Pharmaceutical Company Limited (TSE: 4502) today announced a global, strategic, multi-target collaboration and license agreement for the discovery, development and commercialization of Humabody® -based therapeutics for cancer indications with a high unmet medical […]

read more

AgPlus’ handheld electrochemical reader to deliver the next generation of rapid diagnostics Rainbow Seed Fund, an early-stage venture capital fund focused on promising technologies developed at the UK’s largest publicly-funded research facilities and campuses, today announces its investment into AgPlus Diagnostics, a technology platform developed by scientists at the UK’s National Physical Laboratory (NPL). AgPlus’ […]

read more

Spin out from UK publicly-funded research develops novel laser spectroscopy for environmental, medical diagnosis and industrial process monitoring. Rainbow Seed Fund and Longwall Ventures have invested £1M in MIRICO, a new company developing laser spectroscopy for environmental monitoring, medical diagnosis and industrial process monitoring. The investment will enable MIRICO to take to market its first products, which include new […]

read more

1 2 3 5